Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients - Wikidata - awgldk - TriplyDB

Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients

Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients

http://www.wikidata.org/entity/Q38310999

about

Using Proteomics to Understand How Leishmania Parasites Survive inside the Host and Establish Infection Parasites, proteomes and systems: has Descartes' clock run out of time?Proteomics in India: the clinical aspect Comparative proteomics and glycoproteomics of plasma proteins in Indian visceral leishmaniasis.Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers.Mechanism study of peptide GMBP1 and its receptor GRP78 in modulating gastric cancer MDR by iTRAQ-based proteomic analysis.Comparative Proteomic Analysis of Advanced Ovarian Cancer Tissue to Identify Potential Biomarkers of Responders and Nonresponders to First-Line Chemotherapy of Carboplatin and Paclitaxel.iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells.Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.Proteome profiling of human cutaneous leishmaniasis lesion.Proteomics

P2860

Q26739973-E1CF3AB0-9DB2-4BA4-9F13-ADF27E519F81 Q27010002-590BB7A3-1578-4E3A-9C41-B8542BEAE634 Q28066363-D9A8F7C5-2350-4B00-9178-DDD0BD72ABE6 Q34265738-E03531BE-7FC8-40A4-8C7F-A259BB5063CC Q34388636-C2F4854E-2F49-43EA-A765-602CB13672C0 Q35604249-C584E83A-9643-4F9C-B4DB-F92E87AEABED Q36696710-06CDE262-815E-431E-B777-22F13EF876D6 Q39273231-978CC49A-5422-463E-AF96-5A54FBAB0CFB Q40732977-CF50D4A5-A2B6-4467-8ED3-4E80B4B5CA9C Q41744907-115B2055-BF76-456E-8865-206116642938 Q57251411-1C204CB6-2F96-4B14-94B0-D356F9FE633E

P2860

Two-dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients

http://www.wikidata.org/entity/Q38310999

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Two-dimensional difference gel ...... isceral leishmaniasis patients

@en

type

label

Two-dimensional difference gel ...... isceral leishmaniasis patients

@en

prefLabel

Two-dimensional difference gel ...... isceral leishmaniasis patients

@en

P1433

Q38310999-C9DA15BF-7C5D-4B32-9BB2-72835A2CB221

P1476

Q38310999-A165028D-9B1E-44C4-B363-9198A503BE20

P2093

Q38310999-374EF16F-602F-4BDF-8D43-204FF9ECC6EE

Q38310999-3A968BA8-A505-4012-B70E-03D832F5A158

Q38310999-62B110B9-3D17-469D-B43B-16C45B7826E2

Q38310999-7AEA081D-8637-4CCF-A1F2-47E26E6128E9

Q38310999-E49718FA-05F8-4EDD-86FF-00A3C7E9A867

P2860

Q38310999-15415C1E-3EDD-4800-B8D2-FFC35A797132

Q38310999-1658671A-9686-47AB-8305-A822C390E356

Q38310999-2AEEEDC7-9AFD-4632-AA1D-361302E72916

Q38310999-3392CEF3-77B8-46D8-AF16-0DB7CEAC5AF7

Q38310999-37AA34AC-96A4-49C7-9FCD-A40DA16DF365

Q38310999-3CBA1E69-4E65-46C5-AD12-B0968B0D38D5

Q38310999-3E813DDE-AAE9-4723-A22E-4C5D36CAE4D5

Q38310999-3F27901A-191A-400C-BC7A-ABC0AEDAA350

Q38310999-44BDB720-A9B7-45B9-8239-D22A2B36E01E

Q38310999-5C32C703-082D-481E-8185-97333A8D3652

P2888

Q38310999-3104B1C8-128F-4A40-9638-5E0F2F45EE16

P304

Q38310999-693829F6-08FD-494A-8FF1-604067EBC4E3

P31

Q38310999-226B6224-0DD8-443A-A83B-68C6C8851E9A

P356

Q38310999-8897CC9A-C032-4F96-A13C-A54B72761F60

P433

Q38310999-69FB1485-95C8-45F0-992C-E6C6E4F2EB30

P478

Q38310999-F6162AB5-1B07-4191-A83C-DC96802D5A29

P577

Q38310999-D3A919D0-DA05-4696-84F7-08405E9838CF

P5875

Q38310999-25CD7677-E0EC-46DC-9AEC-773F2D717D1F

P6179

Q38310999-B391A8D7-E12D-4946-B8EF-248BCE34A206

P698

Q38310999-EE5D0F48-5865-4CA4-8832-FBCBE8AE3C18

P921

Q38310999-07864504-5A9D-44D0-A499-6DC3F9F1FDB7

Q38310999-1CE5BED9-D048-463B-9FD3-5BCE8FDFC81C

P932

Q38310999-A1FE9711-DA4F-44F0-A7EE-F49AAC22F4CD

P356

P1433

Clinical Proteomics

P1476

Two-dimensional difference gel ...... isceral leishmaniasis patients

@en

P2093

Alagiri Srinivasan

http://www.w3.org/2001/XMLSchema#string

Gururao Hariprasad

http://www.w3.org/2001/XMLSchema#string

Jitender Kataria

http://www.w3.org/2001/XMLSchema#string

Jyotish C Samantaray

http://www.w3.org/2001/XMLSchema#string

Lokesh A Rukmangadachar

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular diagnosis of leishmaniasis: current status and future applications

The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP

BIOLOGICAL ACTIVITIES OF C1 INHIBITOR

Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?

Efficient and specific removal of albumin from human serum samples.

A novel and accurate diagnostic test for human African trypanosomiasis.

Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum.

Human body fluid proteome analysis.

Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology

Serum proteome of leprosy patients undergoing erythema nodosum leprosum reaction: regulation of expression of the isoforms of haptoglobin.

P2888

P304

4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1559-0275-8-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51637859

http://www.w3.org/2001/XMLSchema#string

P6179

1041577009

http://www.w3.org/2001/XMLSchema#string

P698

21906353

http://www.w3.org/2001/XMLSchema#string

P921

electrophoresis

visceral leishmaniasis

P932

3167202

http://www.w3.org/2001/XMLSchema#string